Skip to content

ASND

Ascendis Pharma A/S

Stock

$227.87+0.56 (+0.25%)Close Oct 2, 2026

Operating cash flow, 2025
€54M

Operating cash flow

Operating cash flow by fiscal year

PeriodOperating cash flowYoY
2025€54M—
2024−€306M—
2023−€467M—
2022−€496M—
2021−€418M—
2020−€272M—
2019−€176M—
2018−€139M—
2017−€95M—
2016−€60M—
2015−€43M—